{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:55:11Z","timestamp":1784544911124,"version":"3.55.0"},"reference-count":24,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T00:00:00Z","timestamp":1229904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate, in a prospective study, the combination of the antimuscarinic propiverine and the antidiuretic hormone\u2010agonist desmopressin in children and adolescents not responsive to previous monotherapy, as in primary monosymptomatic enuresis (PME), combined treatments are considered a second\u2010line approach after the failure of monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PATIENTS AND METHODS<\/jats:title>\n                    <jats:p>The study included 122 children and adolescents (mean age 10.8\u2003years, range 5\u201321) with PME and so far unresponsive to single or multiple monotherapy. Propiverine (body weight &lt;30\u2003kg, 15\u2003mg\/day; \u226530\u2003kg, 20\u2003mg\/day) and desmopressin (0.4\u2003mg\/night) were administered over 3\u2003months, followed by successive structured withdrawal programmes for propiverine and desmopressin, depending on the amount of loss of urine at night before treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The re\u2010evaluation of unresponsive patients, incorporating video\u2010urodynamics, showed neurogenic detrusor overactivity, isolated detrusor sphincter dyssynergia and vesicorenal reflux in 12.3% (15\/122) of patients, so far falsely treated as enuresis. In 107 of 122 patients the diagnosis of PME was confirmed. The primary efficacy outcome, continence at night, was achieved in 104 of 107 patients (97.2%). During the individual follow\u2010up periods (3\u201312\u2003months), 23 of 107 (21.5%) patients relapsed after withdrawal of both medications. Adverse events of moderate intensity were rare (3.7%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Re\u2010evaluation of patients after monotherapy has failed is justified, because other entities can be discovered in patients so far treated unsuccessfully for enuresis. The combination of propiverine and desmopressin is highly effective in children with PME. Our results support the case for further optimizing the inaugurated treatment algorithm of PME for treatment duration, dose\u2010titration and structured withdrawal programmes, thus possibly further decreasing relapse rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2008.08285.x","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T05:42:19Z","timestamp":1229924539000},"page":"1706-1712","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes"],"prefix":"10.1111","volume":"103","author":[{"given":"Saladin Helmut","family":"Alloussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"M\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gitzhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Eichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Madersbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Strugala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schahnaz","family":"Alloussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,27]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"963","volume-title":"Incontinence","author":"Nijman R","year":"2002"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000111504.85822.b2"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/2000-1967-026"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008424"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000169160.84418.15"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00120-004-0587-5"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1995.tb13818.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00595-7"},{"key":"e_1_2_8_10_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000474507","article-title":"Nocturnal enuresis and daytime wetting. A multicentric trial with oxybutynin and desmopressin","volume":"31","author":"Caione P","year":"1997","journal-title":"Eur Urol"},{"key":"e_1_2_8_11_2","first-page":"149","article-title":"Combined oxybutynin\u2010desmopressin therapy in the treatment of nocturnal enuresis with urinary disorders","volume":"51","author":"De Grazia E","year":"1999","journal-title":"Minerva Pediatr"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003450100223"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(06)61129-9"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(06)00305-3"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-4295(83)90079-1"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.10052"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2002.02884.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2007.01.106"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00595916"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1998.0810s3024.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65617-0"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)65775-6"},{"key":"e_1_2_8_23_2","unstructured":"Sill\u00e9nU L\u00e4ckgrenG M\u00fcrtzG SchmidtC.Safety and efficacy of anticholinergic therapy with propiverine in children suffering from overactive bladder. Poster presentation ICS 2007 Available at:http:\/\/www.icsoffice.org\/publications\/2007\/pdf\/0226.pdf. Accessed October 2007"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.05.060"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2008.01.096"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2008.08285.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2008.08285.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:26:56Z","timestamp":1761733616000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2008.08285.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,27]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1464-410X.2008.08285.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2008.08285.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,27]]},"assertion":[{"value":"2009-05-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}